SEARCH

SEARCH BY CITATION

Table S1. (A) HMW–MAA expression level in 40 primary DM lesions. (B) HMW–MAA expression level in 23 metastatic DM lesions from the regional nodes or distant sites.

Table S2. (A) IHC staining intensity of HMW–MAA, MART-1 and HMB-45 of primary DM (n = 40). (B) Distribution of staining in 40 primary DM lesions assessed by IHC for HMW–MAA, MART-1 and HMB-45. (C) IHC staining intensity of HMW–MAA, MART-1 and HMB-45 of metastatic DM (n = 23). (D) Distribution of staining of metastatic DM lesions assessed by IHC for HMW–MAA, MART-1 and HMB-45 (n = 23).

Appendix S1. Materials and Methods.

Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

FilenameFormatSizeDescription
PCMR_660_sm_AppendixS1.doc86KSupporting info item
PCMR_660_sm_tablesS1-2.doc104KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.